Search results
Google site results
Loading...
Wiki results
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:48, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 15:04, 6 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 11:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:47, 3 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:48, 3 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 11:47, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ...lia, but also as AML and they may even present as, or evolve to, precursor T or B lymphoblastic leukaemia/lymphoma with prominent eosinphils." (p.28).10 KB (1,469 words) - 17:05, 11 October 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (887 words) - 13:51, 25 February 2024
- ==Cancer Category/Type== ..., hematopoietic and lymphoid cancers (13.8%), and Melanomas (7%) ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=kit see COSMIC]).7 KB (1,047 words) - 14:32, 12 December 2023
- ==Cancer Category/Type== ...AAT/enhancer-binding proteins beta and gamma to modulate the expression of genes involved in cell cycle regulation. It coordinates proliferation arrest and7 KB (1,051 words) - 13:53, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,368 words) - 15:12, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,391 words) - 18:27, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,389 words) - 18:22, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,392 words) - 18:23, 23 December 2023
- ==Cancer Category/Type== ...urr. Biol. 9: 1373-1381, 1999.</ref><ref>Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adapto5 KB (787 words) - 14:00, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,434 words) - 10:50, 27 February 2024
- ...riginal page can be found at [[HAEM4:Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]]. ==Cancer Category / Type==10 KB (1,386 words) - 14:35, 13 December 2023
- {{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} ==Cancer Category / Type==11 KB (1,530 words) - 14:34, 13 December 2023
- ...e 4th edition was Fibrin-Associated Diffuse Large B-cell Lymphoma and didn't have content. ==Cancer Category / Type==10 KB (1,435 words) - 11:55, 23 December 2023
- [[Category:Somatically Mutated Genes]] ...na, MD, M.D. Anderson Cancer Center and Min Fang, MD, PhD, Fred Hutchinson Cancer Research Center8 KB (1,195 words) - 21:24, 6 August 2016
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:37, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:38, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:43, 25 February 2024
- ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''11 KB (1,545 words) - 14:48, 12 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3]]. ==Cancer Category / Type==10 KB (1,436 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:31, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 10:47, 29 January 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:39, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:41, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:42, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,494 words) - 16:44, 4 March 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,460 words) - 13:26, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,501 words) - 18:38, 27 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==9 KB (1,266 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,506 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- {{DISPLAYTITLE:Subcutaneous panniculitis-like T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:40, 13 December 2023
- {{DISPLAYTITLE:Indolent T-lymphoblastic proliferation}} ==Cancer Category / Type==11 KB (1,512 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- {{DISPLAYTITLE:Extranodal NK/T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:27, 13 December 2023
- {{DISPLAYTITLE:Peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,515 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,520 words) - 11:21, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:39, 13 December 2023
- {{DISPLAYTITLE:T-lymphoblastic leukaemia / lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 15:52, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,533 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:34, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous gamma/delta T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:T-cell/histiocyte-rich large B-cell lymphoma}} ==Cancer Category / Type==11 KB (1,518 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,529 words) - 15:31, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:28, 13 December 2023